Human IL-15 Antibody
R&D Systems, part of Bio-Techne | Catalog # AF315
Scientific images may be resized, cropped, or adjusted for brightness or contrast for presentation purposes. These updates are limited to presentation and do not affect the underlying scientific interpretation of the data. Where available, additional source data may be provided upon request.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Cited:
Human, Feline, Primate - Macaca mulatta (Rhesus Macaque)
Applications
Validated:
Immunohistochemistry, Western Blot, Neutralization
Cited:
Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Western Blot, Neutralization, Immunocytochemistry
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Product Specifications
Immunogen
E. coli-derived recombinant human IL-15
Asn49-Ser162
Accession # P40933
Asn49-Ser162
Accession # P40933
Specificity
Detects human IL-15 in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross-reactivity with recombinant mouse IL‑15 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Scientific Data Images for Human IL-15 Antibody
IL-15 in Human Tonsil.
IL-15 was detected in immersion fixed paraffin-embedded sections of human tonsil using Goat Anti-Human IL-15 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF315) at 10 µg/mL overnight at 4 °C. Before incubation with the primary antibody tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (Catalog # CTS013). Tissue was stained using the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.Cell Proliferation Induced by IL-15 and Neutralization by Human IL-15 Antibody.
Recombinant Human IL-15 (Catalog # 247-IL) stimulates proliferation in the MO7e human megakaryocytic leukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human IL-15 (10 ) is neutralized (green line) by increasing concen-trations of Goat Anti-Human IL-15 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF315). The ND50 is typically 0.5-1.5 µg/mL.Applications for Human IL-15 Antibody
Application
Recommended Usage
Immunohistochemistry
5-15 µg/mL
Sample: Immersion fixed paraffin-embedded sections of human tonsil subjected to Antigen Retrieval Reagent-Basic (Catalog # CTS013)
Sample: Immersion fixed paraffin-embedded sections of human tonsil subjected to Antigen Retrieval Reagent-Basic (Catalog # CTS013)
Western Blot
0.1 µg/mL
Sample: Recombinant Human IL-15 (Catalog # 247-IL)
Sample: Recombinant Human IL-15 (Catalog # 247-IL)
Neutralization
Measured by its ability to neutralize IL‑15-induced proliferation in the MO7e human megakaryocytic leukemic cell line [Avanzi, G. et al. (1988) Br. J. Haematol. 69:359]. The Neutralization Dose (ND50) is typically 0.5-1.5 µg/mL in the presence of 10 ng/mL of Recombinant Human IL‑15.
Reviewed Applications
Read 1 review rated 5 using AF315 in the following applications:
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: IL-15
References
- Grabstein, K. et al. (1994) Science 264:965.
- Budagian, V. et al. (2006) Cytokine Growth Factor Rev. 17:259.
- Ma, A. et al. (2006) Annu. Rev. Immunol. 24:657.
- Tagaya, Y. et al. (1997) Proc. Natl. Acad. Sci. USA 94:14444.
- Giri, J.G. et al. (1995) EMBO 14:3654.
- Giri, J. et al. (1994) EMBO J. 13:2822.
- Duitman, E.H. et al. (2008) Mol. Cell. Biol. 28:4851.
- Dubois, S. et al. (2002) Immunity 17:537.
- Stonier, S.W. and K.S. Schluns (2010) Immunol. Lett. 127:85.
- Burkett, P.R. et al. (2004) J. Exp. Med. 200:825.
- Budagian, V. et al. (2004) J. Biol. Chem. 279:40368.
- Mortier, E. et al. (2004) J. Immunol. 173:1681.
- Bulanova, E. et al. (2007) J. Biol. Chem. 282:13167.
- Budagian, V. et al. (2004) J. Biol. Chem. 279:42192.
- Neely, G.G. et al. (2004) J. Immunol. 172:4225.
Long Name
Interleukin 15
Alternate Names
IL15
Entrez Gene IDs
Gene Symbol
IL15
UniProt
Additional IL-15 Products
Product Documents for Human IL-15 Antibody
Product Specific Notices for Human IL-15 Antibody
For research use only
Loading...
Loading...
Loading...
Loading...
Loading...